Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Booms, Busts, and Recoveries -- Ignore unavailable to you. Want to Upgrade?

To: Maurice Winn who wrote (30500)	3/31/2003 2:29:20 PM
From: energyplay	Read Replies (1) \| Respond to of 74559

Re: SARS - I would expect any mutation would tend to move toward fewer & milder symptons in the early stages. The bug can't get on an airplane if it's host appears to have symptons. This would tend to mean the disease itself will become milder. A slower, milder version would spread faster. If a more virulent starin would come along a week or two later, it would encounter many people with immunity or partial immunity frrom the mild strain. Health authorities everywhere, especailly Hong Kong, seem to be doing a good job of containing SARS. If it turns of that it needs to live in water droplets, people may be a able to susitute gloves for masks (or use both). The SARS thing, if it becomes controlable and/or milder, has the potential for creating some nice investment opportunities in travel related sectors, such a airlines and hotels, which have previously been dragged down by the Bali bombing, Iraq war, higher jet fuel prices, and now SARS. Buy when there's coughing in the streets.